Definium Therapeutics, Inc. DFTX
Set alert
36.33 USD -1.63 -4.29%
At close · Oct 30
36.36 +0.03 +0.09%
After hours · Oct 30, 7:24 PM ET
35.87 Day range 37.90
10.68 52-week range 48.45
- YTD
- +171.32%
- 1 year
- +171.32%
- Open
- 37.24
- Prev close
- 37.96
- Mkt cap
- 4.88B
- Vol
- 1.08M
- Avg vol
- 2.17M
- EPS
- -3.43
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 35.87
- High
- 37.90
- Forward P/E
- -18.72
- Beta
- 2.19
- Short ratio
- 4.32
- Inst. own
- 88.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 37.95
- 200-d avg
- 29.50
- 1y target
- 72.56
MAX chart
Events in this range
- Nov 6, 2025Earnings: -0.78; estimate -0.52; surprise -50%
- May 7, 2026Earnings: -0.71; estimate -0.47; surprise -51.06%
- Aug 6, 2026Earnings: -1.44; estimate -0.54102; surprise -166.16%
Signals (25)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Mar 1, 2026 | 8 months ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bullish | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 1, 2023 | 3 years ago |
| SMA: Bullish | Jun 1, 2023 | 3 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Oct 1, 2021 | 5 years ago |
| SMA: Bearish | Aug 1, 2021 | 5 years ago |
| RSI: Overbought | Oct 1, 2020 | 6 years ago |
| SMA: Bullish | Mar 1, 2020 | 6 years ago |
| RSI: Overbought | Mar 1, 2020 | 6 years ago |
| SMA: Bullish | Feb 1, 2020 | 6 years ago |
| SMA: Bearish | Jan 1, 2020 | 6 years ago |
| SMA: Bullish | Dec 1, 2019 | 6 years ago |
| SMA: Bearish | Nov 1, 2019 | 7 years ago |
| SMA: Bullish | Sep 1, 2019 | 7 years ago |
Financial health
Altman Z-Score
14.05 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -6.5×
FY 2016 5y median -4.5× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.6×
FY 2016 5y median 2.0× FY 2025
P/FCF -9.1×
FY 2016 5y median -6.2× FY 2025
EV/EBITDA -5.3×
FY 2016 5y median -2.3× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -11.0%
FY 2016 5y median -16.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -55.3%
FY 2016 5y median -55.3% FY 2025
ROIC -44.5%
FY 2016 5y median -44.5% FY 2025
ROA -41.8%
FY 2016 5y median -41.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -60.0%
FY 2016 FY 2025
EPS (diluted) -1273.3%
FY 2016 FY 2025
Free Cash Flow -66.3%
FY 2016 FY 2025
Financial Health
Current Ratio 6.3×
FY 2016 5y median 7.2× FY 2025
Quick Ratio 6.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.4×
FY 2016 5y median 1.5× FY 2025
Interest Coverage -30.3×
FY 2016 5y median -45.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31